|
Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control
|
|
Zenith Epigenetics
|
Jan 27, 2023 06:59AM
|
|
Re: Merck's profit on Molnupiravir.
|
3
|
Resverlogix Corp.
|
Oct 08, 2021 08:22AM
|
|
Re: MERCK….
|
2
|
Resverlogix Corp.
|
Oct 01, 2021 01:11PM
|
|
Re: MERK
|
2
|
Resverlogix Corp.
|
Sep 30, 2021 08:46AM
|
|
Re: MERK
|
1
|
Resverlogix Corp.
|
Sep 30, 2021 12:26PM
|
|
Re: Merry Christmas
|
4
|
Resverlogix Corp.
|
Dec 24, 2019 12:46PM
|
|
Re: Mexican stand off....
|
3
|
Resverlogix Corp.
|
Jan 21, 2019 11:47AM
|
|
Re: Miracles do happen SF
|
3
|
Resverlogix Corp.
|
Sep 19, 2020 12:11PM
|
|
Re: Missed Opportunity
|
5
|
Resverlogix Corp.
|
Apr 02, 2024 09:15AM
|
|
Re: Moderna news
|
|
Resverlogix Corp.
|
Aug 13, 2020 07:51PM
|
|
Re: Monday
|
3
|
Resverlogix Corp.
|
Oct 02, 2020 06:03AM
|
|
Re: More Exempt Distribution Investments
|
3
|
Zenith Epigenetics
|
Feb 28, 2024 04:51PM
|
|
Re: More Exempt Distribution Investments
|
1
|
Zenith Epigenetics
|
Jan 05, 2024 03:27PM
|
|
Re: More Exempt Distribution Investments
|
|
Zenith Epigenetics
|
Jan 05, 2024 04:43PM
|
|
Re: More Exempt Distribution Investments
|
5
|
Zenith Epigenetics
|
Jan 05, 2024 05:24PM
|
|
Re: More insider buying
|
2
|
Resverlogix Corp.
|
Jun 27, 2022 10:33AM
|
|
Re: More media
|
3
|
Resverlogix Corp.
|
Jan 24, 2022 10:33AM
|
|
Re: More media
|
1
|
Resverlogix Corp.
|
Jan 24, 2022 10:52AM
|
|
Re: Morocco compared to Saudi
|
2
|
Resverlogix Corp.
|
Nov 03, 2021 06:59AM
|
|
Re: MP's and MLA's
|
2
|
Resverlogix Corp.
|
May 15, 2021 09:50AM
|
